Recomienda este artículo a tus amigos:
Risk / Benefit Analysis for the Use and Approval of Thrombolytic, Antiarrhythmic, and Hypolipidemic Agents: Proceedings of the Ninth Annual Symposium on New Drugs & Devices, October 27 & 28, 1988 - Developments in Cardiovascular Medicine Symposium on New Drugs and Devices
Precio
Mex$ 4.403
sin IVA
Pedido desde almacén remoto
Entrega prevista 13 de nov. - 1 de dic.
Los regalos de Navidad se podrán canjear hasta el 31 de enero
Recibe notificaciones sobre nuevos lanzamientos de Symposium on New Drugs and Devices
Añadir a tu lista de deseos de iMusic
Risk / Benefit Analysis for the Use and Approval of Thrombolytic, Antiarrhythmic, and Hypolipidemic Agents: Proceedings of the Ninth Annual Symposium on New Drugs & Devices, October 27 & 28, 1988 - Developments in Cardiovascular Medicine
Symposium on New Drugs and Devices
Proceedings of the Ninth Annual Symposium on New Drugs & Devices, October 27 and 28, 1988
298 pages, biography
| Medios de comunicación | Libros Hardcover Book (Libro con lomo y cubierta duros) |
| Publicado | 30 de junio de 1989 |
| ISBN13 | 9780792302940 |
| Editores | Kluwer Academic Publishers |
| Páginas | 298 |
| Dimensiones | 156 × 234 × 19 mm · 648 g |
| Lengua | Inglés |
| Editor | Moore, E. Neil |
| Editor | Morganroth, Joel |